![Leon Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Leon Chen
Direttore/Membro del Consiglio presso
Remix Therapeutics, Inc.
Profilo
Leon E.
Chen is the founder of KAI Pharmaceuticals, Inc., founded in 2002.
Current jobs include Director at Remix Therapeutics, Inc. and Partner at The Column Group LLC since 2019.
Former jobs include Director at Crescendo Bioscience LLC, Sutro Biopharma, Inc., Genocea Biosciences, Inc., Velia, Inc., Pionyr Immunotherapeutics, Inc., and Eikon Therapeutics, Inc.; Independent Director at Nurix Therapeutics, Inc. from 2020 to 2021 and LogicBio Therapeutics, Inc. from 2016 to 2022; Chief Executive & Financial Officer at ESCAPE Bio, Inc.; Principal at Venrock Associates in 2007; Partner at Skyline Management LLC from 2010 to 2013; and Venture Partner at OrbiMed Advisors Private Equity from 2013 to 2019.
Education includes a doctorate from Stanford University in 2001, an undergraduate degree from the University of California, Berkeley in 1997, and an MBA from Stanford Graduate School of Business in 2009.
Posizioni attive di Leon Chen
| Società | Posizione | Inizio |
|---|---|---|
The Column Group LLC
 The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Investitore di Private Equity | 01/10/2019 |
Remix Therapeutics, Inc.
 Remix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company develops molecule therapies to modulate RNA processing and address the underlying drivers of diseases | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Leon Chen
| Società | Posizione | Fine |
|---|---|---|
| EIKON THERAPEUTICS, INC. | Amministratore Delegato | - |
| LOGICBIO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 16/11/2022 |
| NURIX THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 28/05/2021 |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Investitore di Private Equity | 30/09/2019 |
ESCAPE Bio, Inc.
 ESCAPE Bio, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics against genetic targets for neurodegenerative disease | Amministratore Delegato | 23/08/2018 |
Formazione di Leon Chen
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
75
Relazioni di 1° grado
18
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 18 |
|---|---|
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Finance |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical drugs | Health Technology |
Crescendo Bioscience LLC
 Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases | Commercial Services |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
Nurix Therapeutics, Inc.
 Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skyline Management LLC
 Skyline Management LLC Investment ManagersFinance Skyline Management invests in companies located in the United States. The firm focuses on companies operating in the fields of healthcare market, including biotechnology, therapeutics, medical devices, consumables and equipment for life sciences research and healthcare information technology. It participates in financing for early stage and later stage transactions with an investment size between USD 15 and 25 million. | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines and therapies for bone metabolism, cardiology, neurology and rare diseases | Health Technology |
Pionyr Immunotherapeutics, Inc.
 Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops antibody-based Immuno-oncology therapeutics | Health Technology |
ESCAPE Bio, Inc.
ESCAPE Bio, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics against genetic targets for neurodegenerative disease | Health Technology |
Eikon Therapeutics, Inc.
 Eikon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical biopharmaceutical company that dedicated to inventing and developing of breakthrough therapeutics | Health Technology |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company develops molecule therapies to modulate RNA processing and address the underlying drivers of diseases | Health Technology |
Velia, Inc.
 Velia, Inc. Packaged SoftwareTechnology Services Provides software development services | Technology Services |
